164 related articles for article (PubMed ID: 24561668)
1. Imidazopyridine-fused [1,3]-diazepinones: synthesis and antiproliferative activity.
Gallud A; Vaillant O; Maillard LT; Arama DP; Dubois J; Maynadier M; Lisowski V; Garcia M; Martinez J; Masurier N
Eur J Med Chem; 2014 Mar; 75():382-90. PubMed ID: 24561668
[TBL] [Abstract][Full Text] [Related]
2. Imidazopyridine-fused [1,3]-diazepinones part 2: Structure-activity relationships and antiproliferative activity against melanoma cells.
Bellet V; Lichon L; Arama DP; Gallud A; Lisowski V; Maillard LT; Garcia M; Martinez J; Masurier N
Eur J Med Chem; 2017 Jan; 125():1225-1234. PubMed ID: 27871038
[TBL] [Abstract][Full Text] [Related]
3. Imidazopyridine-fused [1,3]diazepinones: modulations of positions 2 to 4 and their impacts on the anti-melanoma activity.
Baccon-Sollier PL; Malki Y; Maye M; Ali LMA; Lichon L; Cuq P; Vincent LA; Masurier N
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):935-949. PubMed ID: 32249633
[TBL] [Abstract][Full Text] [Related]
4. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
Park JH; El-Gamal MI; Lee YS; Oh CH
Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of dehydroepiandrosterone-fused thiazole, imidazo[2,1-b]thiazole, pyridine steroidal analogues.
Zhang BL; Song LX; Li YF; Li YL; Guo YZ; Zhang E; Liu HM
Steroids; 2014 Feb; 80():92-101. PubMed ID: 24355392
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxic activity of 5,6-heteroaromatically annulated pyridine-2,4-diamines.
Willemann C; Grünert R; Bednarski PJ; Troschütz R
Bioorg Med Chem; 2009 Jul; 17(13):4406-19. PubMed ID: 19481463
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and structure--activity relationship (SAR) studies of imidazo[4,5-b]pyridine derived purine isosteres and their potential as cytotoxic agents.
Sajith AM; Abdul Khader KK; Joshi N; Reddy MN; Syed Ali Padusha M; Nagaswarupa HP; Nibin Joy M; Bodke YD; Karuvalam RP; Banerjee R; Muralidharan A; Rajendra P
Eur J Med Chem; 2015 Jan; 89():21-31. PubMed ID: 25462222
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticancer activity evaluation of a series of [1,2,4]triazolo[1,5-a]pyridinylpyridines in vitro and in vivo.
Wang XM; Xu J; Li YP; Li H; Jiang CS; Yang GD; Lu SM; Zhang SQ
Eur J Med Chem; 2013 Sep; 67():243-51. PubMed ID: 23871904
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of novel 3-substituted imidazo[1,2-a]pyridine and quinazolin-4(3H)-one derivatives as PI3Kα inhibitors.
Fan YH; Li W; Liu DD; Bai MX; Song HR; Xu YN; Lee S; Zhou ZP; Wang J; Ding HW
Eur J Med Chem; 2017 Oct; 139():95-106. PubMed ID: 28800461
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design, synthesis, and evaluation of imidazo[1,2-b]pyridazine and imidazo[1,2-a]pyridine derivatives as novel dual c-Met and VEGFR2 kinase inhibitors.
Matsumoto S; Miyamoto N; Hirayama T; Oki H; Okada K; Tawada M; Iwata H; Nakamura K; Yamasaki S; Miki H; Hori A; Imamura S
Bioorg Med Chem; 2013 Dec; 21(24):7686-98. PubMed ID: 24216091
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno[2,3-d]pyrimidine derivatives.
Kassab AE; Gedawy EM
Eur J Med Chem; 2013 May; 63():224-30. PubMed ID: 23501108
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxicity of thieno[2,3-b]pyridine and furo[2,3-b]pyridine derivatives.
Hung JM; Arabshahi HJ; Leung E; Reynisson J; Barker D
Eur J Med Chem; 2014 Oct; 86():420-37. PubMed ID: 25194934
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L
Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730
[TBL] [Abstract][Full Text] [Related]
14. Antitumor agents. 5. synthesis, structure-activity relationships, and biological evaluation of dimethyl-5H-pyridophenoxazin-5-ones, tetrahydro-5h-benzopyridophenoxazin-5-ones, and 5h-benzopyridophenoxazin-5-ones with potent antiproliferative activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Novellino E; Pepe S
J Med Chem; 2006 Aug; 49(17):5110-8. PubMed ID: 16913700
[TBL] [Abstract][Full Text] [Related]
15. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel 4-aryl-thieno[1,4]diazepin-2-one derivatives targeting multiple protein kinases as anticancer agents.
Lee J; Jung H; Kim M; Lee E; Im D; Aman W; Hah JM
Bioorg Med Chem; 2018 May; 26(8):1628-1637. PubMed ID: 29459144
[TBL] [Abstract][Full Text] [Related]
17. Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7.
Arama DP; Soualmia F; Lisowski V; Longevial JF; Bosc E; Maillard LT; Martinez J; Masurier N; El Amri C
Eur J Med Chem; 2015 Mar; 93():202-13. PubMed ID: 25682203
[TBL] [Abstract][Full Text] [Related]
18. Tetrahydropyrrolo[3,2-c]azepin-4-ones as a new class of cytotoxic compounds.
Martínez R; Avila JG; Ramírez MT; Pérez A; Martínez A
Bioorg Med Chem; 2006 Jun; 14(12):4007-16. PubMed ID: 16504513
[TBL] [Abstract][Full Text] [Related]
19. 5-Substituted [1]pyrindine derivatives with antiproliferative activity.
Kolb S; Goddard ML; Loukaci A; Mondésert O; Ducommun B; Braud E; Garbay C
Eur J Med Chem; 2010 Mar; 45(3):896-901. PubMed ID: 19969400
[TBL] [Abstract][Full Text] [Related]
20. Thee-component, one-pot synthesis of hexahydroazepino[3,4-b]indole and tetrahydro-1H-pyrido[3,4-b]indole derivatives and evaluation of their cytotoxicity.
Reddy BVS; Venkata Ganesh A; Vani M; Ramalinga Murthy T; Kalivendi SV; Yadav JS
Bioorg Med Chem Lett; 2014 Sep; 24(18):4501-4503. PubMed ID: 25176193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
